ZA941674B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA941674B
ZA941674B ZA941674A ZA941674A ZA941674B ZA 941674 B ZA941674 B ZA 941674B ZA 941674 A ZA941674 A ZA 941674A ZA 941674 A ZA941674 A ZA 941674A ZA 941674 B ZA941674 B ZA 941674B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
hydroxyacetanilide
cysteine
precursor
shaping
Prior art date
Application number
ZA941674A
Other languages
English (en)
Inventor
Roger Spencer Jones
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA941674B publication Critical patent/ZA941674B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA941674A 1993-03-12 1994-03-10 Pharmaceutical compositions ZA941674B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305058A GB9305058D0 (en) 1993-03-12 1993-03-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA941674B true ZA941674B (en) 1995-09-11

Family

ID=10731916

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941674A ZA941674B (en) 1993-03-12 1994-03-10 Pharmaceutical compositions

Country Status (20)

Country Link
US (2) US5716991A (pt)
EP (2) EP1210939B1 (pt)
JP (1) JPH08507305A (pt)
KR (1) KR960700701A (pt)
CN (1) CN1118989A (pt)
AT (2) ATE221777T1 (pt)
AU (1) AU674934B2 (pt)
BR (1) BR9406227A (pt)
CA (1) CA2157921C (pt)
DE (2) DE69431151T2 (pt)
DK (1) DK0689434T3 (pt)
ES (2) ES2254541T3 (pt)
GB (2) GB9305058D0 (pt)
IL (1) IL108937A (pt)
NO (1) NO318493B1 (pt)
NZ (1) NZ262168A (pt)
PT (1) PT689434E (pt)
SG (1) SG48344A1 (pt)
WO (1) WO1994020086A1 (pt)
ZA (1) ZA941674B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5882298A (en) * 1997-01-29 1998-08-18 Chong Kun Dang Corporation New analgesic composition
AU4085201A (en) * 2000-03-15 2001-09-24 Imperial College Innovations Limited Pharmaceutical composition
KR100379155B1 (ko) * 2000-07-18 2003-04-08 삼진제약주식회사 새로운 진통제 조성물
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20080188439A1 (en) * 2006-10-26 2008-08-07 Salhanick Steven D Directed metabolism of compounds by glucuronidation and sulfonation donors to decrease toxicity
ITMI20080187A1 (it) * 2008-02-07 2009-08-08 Velleja Res Srl Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo
US20110014285A1 (en) * 2009-07-15 2011-01-20 Herzenberg Leonore A N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu
GB1287431A (en) * 1969-04-16 1972-08-31 Aspro Nicholas Ltd Improvements in pharmaceutical formulations
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
GB1410909A (en) * 1971-10-26 1975-10-22 Sterling Winthrop Group Ltd Pharmaceutical compositions
GB1463505A (en) * 1973-11-21 1977-02-02 Nat Res Dev Pharmaceutical compositions
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
EP0040472B1 (en) * 1980-05-20 1986-01-29 Mallinckrodt, Inc. (a Delaware corporation) Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
IE55579B1 (en) * 1982-07-06 1990-11-07 Sterwin Ag Processes for preparing tablets by a modified'wet-granulation'technique
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
EP0481294B2 (de) * 1990-10-19 2001-04-11 Spirig Ag Pharmazeutische Präparate Feste, schnell-lösliche Arzneimittelzubereitung enthaltend N-Acetylcystein
US5474757A (en) * 1992-10-16 1995-12-12 Rutgers University Prevention of acetaminophen overdose toxicity with organosulfur compounds
FR2708602B1 (fr) * 1993-08-02 1995-10-06 Oreal Procédé d'extraction des composés malodorants présents dans une formulation contenant au moins un composé comportant un groupe thiol et compositions désodorisées ainsi obtenues.
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
JPH07130367A (ja) * 1993-10-29 1995-05-19 Sony Corp リチウム二次電池用正極活物質の製造方法

Also Published As

Publication number Publication date
GB2276319A (en) 1994-09-28
NO318493B1 (no) 2005-03-29
US5716991A (en) 1998-02-10
AU674934B2 (en) 1997-01-16
SG48344A1 (en) 1998-04-17
GB9404427D0 (en) 1994-04-20
IL108937A0 (en) 1994-06-24
US5852055A (en) 1998-12-22
PT689434E (pt) 2002-12-31
WO1994020086A1 (en) 1994-09-15
ES2254541T3 (es) 2006-06-16
NZ262168A (en) 1997-05-26
DK0689434T3 (da) 2002-12-02
DE69434600T2 (de) 2006-08-24
ES2176238T3 (es) 2002-12-01
BR9406227A (pt) 1995-12-12
IL108937A (en) 1999-10-28
NO953515D0 (no) 1995-09-07
GB9305058D0 (en) 1993-04-28
EP0689434B1 (en) 2002-08-07
DE69434600D1 (de) 2006-03-30
EP1210939B1 (en) 2006-01-04
CA2157921A1 (en) 1994-09-15
ATE314842T1 (de) 2006-02-15
JPH08507305A (ja) 1996-08-06
DE69431151T2 (de) 2002-12-12
KR960700701A (ko) 1996-02-24
DE69431151D1 (de) 2002-09-12
ATE221777T1 (de) 2002-08-15
EP1210939A2 (en) 2002-06-05
NO953515L (no) 1995-09-07
AU6148794A (en) 1994-09-26
CA2157921C (en) 2006-07-11
CN1118989A (zh) 1996-03-20
GB2276319B (en) 1997-01-15
EP1210939A3 (en) 2002-08-07
EP0689434A1 (en) 1996-01-03

Similar Documents

Publication Publication Date Title
AU643489B2 (en) Antibacterial agents - II
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
AU588837B2 (en) Polypeptide
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
GB2364304A (en) Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
IL128672A0 (en) A process for the production of solid pharmaceutical forms
HUT66143A (en) Acylating agent which is produced by reacting of polyisobutene and enophile compound and process for its producing and using
GB9305058D0 (en) Pharmaceutical compositions
AU7242687A (en) Nucleic acid and methods for the synthesis of novel DAF compositions
CA2136071A1 (en) 2-arylpropionic acid compositions and process for preparing the same
IL94650A0 (en) Processes for preparation of tigogenin betacellobioside
HUT39601A (en) Process for producing synergistic contraceptive compositions
HUT46909A (en) Process for production of substituated quinoxanileimidasoline-2,4-dions and medical preparatives containing such compositions
AU562271B2 (en) Pharmaceutical composition of corazepam and diphenhydramine
AU2594788A (en) Compositions for the production of magnets and magnets produced therefrom
HU904936D0 (en) Process for producing new compounds
HUT57746A (en) Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same
ES8305712A1 (es) Procedimiento para la preparacion de alquilo inferior 1,4-dialquiloinferior-3-alcoxiin-feriorcarbonil-pirrol-2-acetato.
HU896628D0 (en) Process for the preparation of novel apovincamine acid anhydrides and pharmaceutical compositions thereof